Jean‐Yves Douillard - Researcher Profile

Publications

2 shown

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka , Seiji Yano , Giuseppe Giaccone +17 more

Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839]; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine ki...

2003 Journal of Clinical Oncology 2877 citations

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck , R. Kaiser , Anders Mellemgaard +11 more

2014 The Lancet Oncology 923 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,800
Institution: Universitair Ziekenhuis Leuven

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6540-7333

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.